Breast Cancer
News
How useful are circulating tumor cells for early diagnosis?
Their link with metastases, and thus with aggressive tumors, gives them an advantage over other (noninvasive or minimally invasive) biomarkers in...
Opinion
The unique approach involved in age-specific concerns surrounding young patients with breast cancer
We need to take care of many things, which can go from their job, family, fertility, and all these things are specific to these women and can...
Latest News
Black women have higher state-level rates of TNBC
The state-level disparities highlight gaps in physicians’ understanding of how social factors contribute to disparities in TNBC risk.
News
Breast cancer less common in Black women, so why do more die?
This mortality gap likely reflects the fact that Black women face substantial barriers to obtaining timely, high-quality medical care, compared...
News
Breast cancer now leading cause of cancer death in Black women
"Black women are 41% more likely to die from breast cancer than White women despite a lower risk of being diagnosed with the disease."
Latest News
Radiologist fatigue affects breast imaging interpretation
The impact of time and experience on overall patient recall and false-positive rates has not been well-studied.
News
The evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapies
“The fact that we’re now talking about fourth- and fifth-line therapies for HER2-positive MBC represents a major advance in the management of...
Latest News
Liquid biopsy in metastatic breast cancer management: Where does it stand in clinical practice?
Liquid biopsies — blood analyses that allow oncologists to detect circulating tumor cells and circulating tumor DNA in the blood — are...
Latest News
Biomarker testing in metastatic breast cancer management: ‘Essential’
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
Latest News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...